Immunotherapy for Renal-Cell Carcinoma Saves Lives

A 5-year randomised, placebo-controlled trial of pembrolizumab found a 38% reduction in death vs placebo.
Medscape News UK

source https://www.medscape.com/s/viewarticle/immunotherapy-renal-cell-carcinoma-saves-lives-2024a10007ij?src=rss